Over time, technology has significantly contributed to health care advancements. Some of these enhancements are now considered routine components of care and include electronic health record,...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...

After years of relatively limited therapeutic advancement, the bladder cancer treatment landscape is evolving rapidly. As the sixth most common cancer in the United States,1 bladder cancer is...

October 1, 2025 publications 2025 Medicaid Pharmacy Trend Report In the 2025 Medicaid Pharmacy trend report, we look back on the last 10 years of Medicaid pharmacy economics, providing data-based...

Looking for something? Patient login Already using Home Delivery by Prime Therapeutics Pharmacy? Log in here Mail Please take our survey and tell us how we're doing. [insert short link or use a...

Through our person-centered approach, we help coordinate care across multiple providers for members who are at risk for drug abuse or misuse. Targeted provider outreach 1 Mental illness. (March...

Manufacturer contact form Save a copy to your desktop and fill out the details. Access the form Louisiana Department of Health and Hospitals Louisiana Medicaid program Prior Authorization Schedule...

Expert staff Tap into our insurance expertise to ensure you get the most from your benefits. Specialized care Get info and help managing your condition from specially trained pharmacists and...

Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...

90-day supply Depending on plan design, you may be able to get a 90-day supply of your medicine for less than three 30-day fills. Registered pharmacists Dedicated pharmacists can help get your meds...

Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts

Recent studies have reported an incidence of TA-TMA spanning from 2% to 39%. Such wide variability is thought to stem from inconsistent diagnostic definitions as well as the inclusion of both...

August 26, 2026 Author: Caroline Quinn, PharmD, BCOP Few advances have shaped modern oncology more profoundly than the ability to match the right patient to the right therapy. Biomarkers play a...

Appetite For Change uses food as a tool to build health, wealth and social change. “For youth experiencing homelessness, the Prime Together Foundation’s donation helps The Bridge for Youth go...

References Ma L, Guo H, Zhao Y, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Nature. 2024;9(336). McDowell S. Liquid biopsies: past, present, and future....

During the initial CAR T-cell therapy period, the total cost of care ranged from $350,000 to more than $2 million

Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...

Notice of privacy practices Effective Date: January 2026 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

Education information Biometric information Legally protected classification characteristics We collect this information directly from you when you provide it by applying for a job, accepting a job...

Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...

Abby Kim, PharmD, BCOP, shares how artificial intelligence and novel screening tools are helping to prevent and detect cancer better and sooner

cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...

Cover image for Drug approvals Critical updates in an ever-changing environment  Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...

Cover image for Summer 2023 Prime Therapeutics Report Gene Therapy Update Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pt_summer_report_pdf?fr=xKAE9_zU1NQ Explore the report ...

Prime Therapeutics will add Humira biosimilars in the same position in its formulary as the original drug, joining other pharmaceutical benefit managers in announcing similar policies

Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage

cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...

cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Cover image This high-level drug overview analyzes medical pharmacy claims across commercial, Medicare and Medicaid populations. Prime Therapeutics /2026-medical-pharmacy-trend-report-part-2 The...

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Prime is honored to announce its information technology (IT) department’s Quality Excellence Center (QEC), together with Infosys, received the North American Software Testing Award (NASTA) for Best...